InvestorsHub Logo

Biobillionair

10/30/20 7:15 AM

#307465 RE: alm2 #307446

Alm- Kaiser study

Collaborator:
Amarin Corporation




https://clinicaltrials.gov/ct2/show/NCT04505098?term=VASCEPA&draw=2&rank=6

Why didn’t Amarin just donate a whole bunch of Vascepa to just see if it helped / worked in covid



They/Amarin did...see Kaiser study.


Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 16500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Pragmatic randomized clinical trial
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults (MITIGATE)
Actual Study Start Date : August 7, 2020
Estimated Primary Completion Date : August 7, 2021
Estimated Study Completion Date : February 28, 2023


BB